Lakwa ke rogiyon par tDCS macine awam speech therapy (CILT) ka prabhav.

Effect of monocephalic and bicephalic tDCS in conjunction with constraint-induced language therapy (CILT) on post stroke aphasia: A double blind randomize control trial. - tDCS & Aphasia

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016676

Enrollment

180

Registered

2018-12-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I634- Cerebral infarction due to embolism of cerebral arteries Health Condition 2: I633- Cerebral infarction due to thrombosis of cerebral arteries Health Condition 3: I611- Nontraumatic intracerebral hemorrhage in hemisphere, cortical

Interventions

Intervention1: Arm 1: anode tDCS and CILT: Anodal tDCS stimulation with an anodal electrode over the left Brocas area and return electrode over contra-lateral shoulder area will be applied. 12 session

Eligibility

Inclusion criteria

Inclusion criteria: 1. Post stroke motor aphasia 2. 3 months to 2 years post onset 3. Age between 18 to 75 years 4. Able to speak Hindi language 5. Being right handed 6. Able to participate in intensive therapy

Exclusion criteria

Exclusion criteria: 1. Recurrent stroke resulting in aphasia 2. Seizure in past 12 months 3. Brain surgery or craniotomy in past 4. Premorbid dementia 5. Premorbid psychiatric illness 6. Alcohol or drugs abuse 7. Cardiac pacemaker or cochlear implant 8. Global or Wernickeâ??s aphasia (Shortened Token Test score 9. Residual Aphasia (Shortened Token Test score > 28)

Design outcomes

Primary

Measure	Time frame
1.The Frenchay Aphasia Screening Test (FAST) 2. Neuroimaging (fMRI) 3. Western Aphasia Battery- Revised (WAB-R); Aphasia Quotient Timepoint: 1.The Frenchay Aphasia Screening Test (FAST) at baseline, after 6 weeks and after 12 weeks 2. Neuroimaging (fMRI) at baseline, and after 6 weeks 3. Western Aphasia Battery- Revised (WAB-R); Aphasia Quotient at baseline, after 6 weeks and after 12 weeks	—

Secondary

Measure	Time frame
1. FIM 2. NIHSS 3. Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)- Hindi 4. tDCS adverse affect assessment Timepoint: 1. FIM at baseline, after 6 weeks, and 12 weeks 2. NIHSS at baseline, after 6 weeks, and 12 weeks 3. Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)-Hindi at baseline, after 6 weeks, and 12 weeks 4. tDCS adverse affect assessment after 12 sessions of tDCS	—

Countries

India

Contacts

Public ContactBaijnath Roy

All India Institute of Medical Sciences, New Delhi

vasanthapadma123@gmail.com9868398261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026